Literature DB >> 22326283

Hepatitis C virus Core protein overcomes stress-induced premature senescence by down-regulating p16 expression via DNA methylation.

Joo Song Lim1, Sun-Hye Park, Kyung Lib Jang.   

Abstract

Hepatitis C virus Core plays a vital role in the development of hepatocellular carcinoma; however, the mechanism is still controversial. Here, we show that Core overcomes premature senescence provoked by a reactive oxygen species inducer, H2O2, in human liver cells. For this effect, Core down-regulated levels of p16 via promoter hypermethylation and subsequently induced phosphorylation of Rb in the presence of H2O2. Levels of p21 and p27, however, were little affected by Core under the condition. The potentials of Core to inactivate Rb and suppress H2O2-mediated cellular senescence were abolished when levels of p16 were recovered by either exogenous complementation or inhibition of DNA methylation. Considering that cellular senescence provoked by oxidative stresses is an important tumor suppression process, our present study provides a new strategy by which HCV promotes development of hepatocellular carcinoma.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22326283     DOI: 10.1016/j.canlet.2012.01.044

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  26 in total

Review 1.  Towards incorporating epigenetic mechanisms into carcinogen identification and evaluation.

Authors:  Zdenko Herceg; Marie-Pierre Lambert; Karin van Veldhoven; Christiana Demetriou; Paolo Vineis; Martyn T Smith; Kurt Straif; Christopher P Wild
Journal:  Carcinogenesis       Date:  2013-06-07       Impact factor: 4.944

Review 2.  Smad3 phospho-isoform signaling in hepatitis C virus-related chronic liver diseases.

Authors:  Takashi Yamaguchi; Katsunori Yoshida; Miki Murata; Koichi Matsuzaki
Journal:  World J Gastroenterol       Date:  2014-09-21       Impact factor: 5.742

Review 3.  Cellular senescence associated immune responses in liver cancer.

Authors:  Tim F Greten; Tobias Eggert
Journal:  Hepat Oncol       Date:  2017-11-17

Review 4.  Pathogenesis and prevention of hepatitis C virus-induced hepatocellular carcinoma.

Authors:  Yujin Hoshida; Bryan C Fuchs; Nabeel Bardeesy; Thomas F Baumert; Raymond T Chung
Journal:  J Hepatol       Date:  2014-11-03       Impact factor: 25.083

5.  Regulation of gene expression in HBV- and HCV-related hepatocellular carcinoma: integrated GWRS and GWGS analyses.

Authors:  Xu Zhou; Hua-Qiang Zhu; Jun Lu
Journal:  Int J Clin Exp Med       Date:  2014-11-15

Review 6.  Oxidative stress and hepatic Nox proteins in chronic hepatitis C and hepatocellular carcinoma.

Authors:  Jinah Choi; Nicole L B Corder; Bhargav Koduru; Yiyan Wang
Journal:  Free Radic Biol Med       Date:  2014-05-06       Impact factor: 7.376

7.  MicroRNA-486-5p enhances hepatocellular carcinoma tumor suppression through repression of IGF-1R and its downstream mTOR, STAT3 and c-Myc.

Authors:  Rana Ahmed Youness; Hend Mohamed El-Tayebi; Reem Amr Assal; Karim Hosny; Gamal Esmat; Ahmed Ihab Abdelaziz
Journal:  Oncol Lett       Date:  2016-07-27       Impact factor: 2.967

Review 8.  Production and pathogenicity of hepatitis C virus core gene products.

Authors:  Hui-Chun Li; Hsin-Chieh Ma; Chee-Hing Yang; Shih-Yen Lo
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

9.  Exploring genome-wide DNA methylation profiles altered in hepatocellular carcinoma using Infinium HumanMethylation 450 BeadChips.

Authors:  Jing Shen; Shuang Wang; Yu-Jing Zhang; Hui-Chen Wu; Muhammad G Kibriya; Farzana Jasmine; Habibul Ahsan; David P H Wu; Abby B Siegel; Helen Remotti; Regina M Santella
Journal:  Epigenetics       Date:  2012-12-03       Impact factor: 4.528

Review 10.  Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma.

Authors:  Alla Arzumanyan; Helena M G P V Reis; Mark A Feitelson
Journal:  Nat Rev Cancer       Date:  2013-02       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.